NFKB1 and Alzheimer disease: AD-Exos enriched with miR-873a-5p could promote the M2 phenotype transformation of microglia in the early stage of TBI and inhibit microglia-mediated neuroinflammation, thus improving neurological deficits after TBI by inhibiting the Erk/NF-κB signaling pathway.